OptimizeRx Price to Sales Ratio 2010-2022 | OPRX

Historical PS ratio values for OptimizeRx (OPRX) over the last 10 years. The current P/S ratio for OptimizeRx as of February 03, 2023 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
OptimizeRx P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2023-02-03 18.99 5.38
2022-09-30 14.82 $3.53 4.20
2022-06-30 27.39 $3.57 7.66
2022-03-31 37.71 $3.56 10.61
2021-12-31 62.11 $3.48 17.83
2021-09-30 85.55 $3.44 24.84
2021-06-30 61.90 $3.26 18.97
2021-03-31 48.75 $3.11 15.68
2020-12-31 31.16 $2.93 10.63
2020-09-30 20.85 $2.38 8.78
2020-06-30 13.03 $2.02 6.44
2020-03-31 9.06 $1.93 4.69
2019-12-31 10.27 $1.81 5.67
2019-09-30 14.48 $1.81 7.98
2019-06-30 16.20 $1.88 8.62
2019-03-31 12.72 $1.80 7.07
Sector Industry Market Cap Revenue
Computer and Technology Computer Software $0.326B $0.061B
OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.
Stock Name Country Market Cap PE Ratio
Oracle (ORCL) United States $241.638B 22.35
Salesforce (CRM) United States $171.040B 90.02
SAP SE (SAP) Germany $142.293B 55.85
VMware (VMW) United States $51.804B 31.38
BlackBerry (BB) Canada $2.592B 0.00
PROS Holdings (PRO) United States $1.313B 0.00